Data as of Q4 2025 (Dec 31, 2025)

AVITA MEDICAL, INC.

(RCEL)

Financial Statements · SEC EDGAR XBRL

Revenue
$71.6M
+11.5%
Net Income
-$48.6M
+21.4%
EPS
$-1.74
+27.2%
Gross Margin
82.1%
Op. Income
-$42.5M
+24.8%
FCF
-$32.2M
+44.6%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$71.6M
$64.3M
$50.1M
$34.4M
$29.2M
$71.6M
$64.3M
$50.1M
$34.4M
$29.2M
$12.8M
$9.1M
$7.8M
$6.0M
$5.9M
$58.8M
$55.2M
$42.4M
$28.4M
$23.3M
$20.8M
$20.4M
$20.8M
$13.9M
$14.8M
$101.3M
$111.8M
$86.4M
$59.1M
$51.9M
-$42.5M
-$56.6M
-$42.7M
-$27.5M
-$26.5M
$5.0M
$5.4M
$1.1M
$16K
$22K
-$1.0M
$163K
$8.5M
$892K
-
-$48.6M
-$61.8M
-$35.3M
-$26.6M
-$26.5M
$11K
$54K
$66K
$36K
$38K
-$48.6M
-$61.8M
-$35.4M
-$26.7M
-$26.6M
$-1.74
$-2.39
$-1.40
$1.07
$1.17
$-1.74
$-2.39
$-1.40
$1.07
$1.17
27.9M
25.9M
25.3M
25.0M
22.7M